Computational Drug Discovery Course

Presentations


Morning sessions:

Structural Quality Assurance

The nuclear receptor ligand-binding domain: structure and function

Integration of Virtual and High-throughput Screening


Afternoon sessions:

Strategies for the determination of pharmacophoric 3D database queries

QSAR and 3D QSAR in Drug Design, Part 2: applications and problems

Implications of Protein Flexibility for Drug Discovery

ADMET In Silico Modelling: Towards a Prediction Paradise ?